• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

输注后外源性腺苷在人体中的药代动力学。

Pharmacokinetics of exogenous adenosine in man after infusion.

作者信息

Blardi P, Laghi Pasini F, Urso R, Frigerio C, Volpi L, De Giorgi L, Di Perri T

机构信息

Istituto di Clinica Medica, Università di Siena, Italy.

出版信息

Eur J Clin Pharmacol. 1993;44(5):505-7. doi: 10.1007/BF00315554.

DOI:10.1007/BF00315554
PMID:8359193
Abstract

The plasma kinetics of adenosine was investigated in healthy volunteers after a 1 minute infusion of 2.5, 5 and 10 mg (38.79 and 148 micrograms.kg-1 respectively) and after infusion of 200 micrograms.kg-1 in 10 min followed by 400 micrograms.kg-1 in 10 min. As the dose in the 1 min infusion study was increased the mean CL of adenosine decreased (10.7, 4.70 and 4.14 l.min-1, respectively), its mean half-life increased (0.91, 1.24 and 1.86 min, respectively), and the mean volume of distribution did not show any clear trend (8-13 l). After the 20 minute infusion the plasma level of adenosine reached a peak value comparable to that observed after infusion of 5 mg in 1 min (about 0.5 micrograms.ml-1), but the mean clearance and half-life were significantly different (12.1 l.min-1 and 0.63 min respectively). In all the subjects the plasma concentration of adenosine had returned to the baseline value in 5-15 min after the end of the infusion.

摘要

在健康志愿者中,研究了分别以2.5毫克、5毫克和10毫克(分别为38.79和148微克·千克⁻¹)静脉输注1分钟后,以及先以200微克·千克⁻¹静脉输注10分钟、再以400微克·千克⁻¹静脉输注10分钟后腺苷的血浆动力学。在1分钟输注研究中,随着剂量增加,腺苷的平均清除率降低(分别为10.7、4.70和4.14升·分钟⁻¹),平均半衰期延长(分别为0.91、1.24和1.86分钟),平均分布容积未呈现明显趋势(8 - 13升)。在20分钟输注后,腺苷的血浆水平达到的峰值与1分钟输注5毫克后观察到的峰值相当(约0.5微克·毫升⁻¹),但平均清除率和半衰期显著不同(分别为12.1升·分钟⁻¹和0.63分钟)。在所有受试者中,输注结束后5 - 15分钟内,腺苷的血浆浓度均恢复至基线值。

相似文献

1
Pharmacokinetics of exogenous adenosine in man after infusion.输注后外源性腺苷在人体中的药代动力学。
Eur J Clin Pharmacol. 1993;44(5):505-7. doi: 10.1007/BF00315554.
2
Pharmacokinetics of the infusion of alfentanil in man.
Br J Anaesth. 1983 Nov;55(11):1077-81. doi: 10.1093/bja/55.11.1077.
3
Pharmacokinetic studies of highly purified human prolactin in normal human subjects.正常人体中高纯度人催乳素的药代动力学研究。
J Clin Endocrinol Metab. 1987 Aug;65(2):299-304. doi: 10.1210/jcem-65-2-299.
4
Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
Clin Endocrinol (Oxf). 1984 May;20(5):555-64. doi: 10.1111/j.1365-2265.1984.tb00104.x.
5
Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.健康志愿者多次静脉输注后硝酸甘油的剂量依赖性药代动力学。
J Pharmacokinet Biopharm. 1985 Apr;13(2):143-57. doi: 10.1007/BF01059395.
6
The pharmacokinetics of the beta 2-adrenoceptor agonist fenoterol in healthy women.β2肾上腺素能激动剂非诺特罗在健康女性体内的药代动力学。
Eur J Clin Pharmacol. 1992;43(6):663-5. doi: 10.1007/BF02284970.
7
Pharmacokinetics of ritodrine administered intravenously: recommendations for changes in the current regimen.静脉注射利托君的药代动力学:对当前治疗方案变更的建议
Am J Obstet Gynecol. 1990 Feb;162(2):429-37. doi: 10.1016/0002-9378(90)90401-r.
8
Pharmacokinetics of cefepime in subjects with renal insufficiency.头孢吡肟在肾功能不全受试者中的药代动力学。
Clin Pharmacol Ther. 1990 Sep;48(3):268-76. doi: 10.1038/clpt.1990.149.
9
Pharmacokinetics and tolerability of intravenous infusion of adenosine (SUNY4001) in healthy volunteers.健康志愿者静脉输注腺苷(SUNY4001)的药代动力学及耐受性
Br J Clin Pharmacol. 2000 Aug;50(2):177-81. doi: 10.1046/j.1365-2125.2000.00214.x.
10
Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.通过持续输注吲哚菁绿评估健康受试者的肝血流量。
Br J Clin Pharmacol. 1991 Dec;32(6):697-704.

引用本文的文献

1
Enzyme-mediated depletion of methylthioadenosine restores T cell function in MTAP-deficient tumors and reverses immunotherapy resistance.酶介导的甲基硫腺苷耗竭恢复 MTAP 缺陷肿瘤中的 T 细胞功能并逆转免疫治疗耐药性。
Cancer Cell. 2023 Oct 9;41(10):1774-1787.e9. doi: 10.1016/j.ccell.2023.09.005. Epub 2023 Sep 28.
2
Extracellular cAMP: The Past and Visiting the Future in cAMP-Enriched Extracellular Vesicles.细胞外 cAMP:富含 cAMP 的细胞外囊泡的过去与未来。
Adv Biol (Weinh). 2021 Dec;5(12):e2101064. doi: 10.1002/adbi.202101064. Epub 2021 Oct 28.
3
Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs.

本文引用的文献

1
Dipyridamole inhibition of adenosine metabolism in human blood.双嘧达莫对人体血液中腺苷代谢的抑制作用。
Eur J Pharmacol. 1983 Sep 16;93(1-2):21-6. doi: 10.1016/0014-2999(83)90026-2.
2
Turnover of adenosine in plasma of human and dog blood.
Am J Physiol. 1989 Apr;256(4 Pt 1):C799-806. doi: 10.1152/ajpcell.1989.256.4.C799.
3
Haemodynamic and metabolic effects of infused adenosine in man.人体输注腺苷后的血流动力学和代谢效应。
Clin Sci (Lond). 1990 Aug;79(2):131-8. doi: 10.1042/cs0790131.
非腺苷受体药物中的腺苷相关机制。
Cells. 2020 Apr 13;9(4):956. doi: 10.3390/cells9040956.
4
Physiology and effects of nucleosides in mice lacking all four adenosine receptors.缺乏所有四种腺苷受体的小鼠中的核苷的生理学和作用。
PLoS Biol. 2019 Mar 1;17(3):e3000161. doi: 10.1371/journal.pbio.3000161. eCollection 2019 Mar.
5
Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.腺苷激酶是预防缺血性神经元死亡的一个新的治疗靶点。
Open Drug Discov J. 2010 Jan 1;2(3):108-118.
6
The ischemic preconditioning effect of adenosine in patients with ischemic heart disease.腺苷对缺血性心脏病患者的缺血预处理作用。
Cardiovasc Ultrasound. 2009 Nov 5;7:52. doi: 10.1186/1476-7120-7-52.
7
Pharmacokinetics and tolerability of intravenous infusion of adenosine (SUNY4001) in healthy volunteers.健康志愿者静脉输注腺苷(SUNY4001)的药代动力学及耐受性
Br J Clin Pharmacol. 2000 Aug;50(2):177-81. doi: 10.1046/j.1365-2125.2000.00214.x.
4
Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.腺苷。对其在心脏诊断程序及阵发性室上性心动过速治疗中的应用评估。
Drugs. 1991 Apr;41(4):596-624. doi: 10.2165/00003495-199141040-00007.